Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03669718
Title A Randomized Phase 2 Study of Cemiplimab +/- ISA101b in HPV16-Positive OPC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ISA Pharmaceuticals
Indications

oropharynx cancer

squamous cell carcinoma

Therapies

Cemiplimab + ISA101b

Cemiplimab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL


No variant requirements are available.